Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ALG1 like 1, pseudogene (ALG1L1P) is a genetic element classified as a pseudogene, meaning it has sequence similarity to the protein-coding gene ALG1L1 but is not known to encode a functional protein. Pseudogenes are typically non-transcribed or non-translated, often arising from duplications or mutations of ancestral genes. There is no evidence that ALG1L1P serves as a therapeutic target, nor is it known to play roles in cellular signaling, disease, or drug interactions. It should not be confused with the protein-coding gene ALG1 (chitobiosyldiphosphodolichol beta-mannosyltransferase), which is a glycosyltransferase involved in N-linked glycosylation and is clinically relevant[1][2]. "Pseudogene" status means ALG1L1P does not function as a receptor, enzyme, transporter, or similar target class. Occasionally, pseudogenes are implicated in regulatory RNA functions, but no such function is documented for ALG1L1P. Any association with glycosylation pathways attributed to the functional ALG1 or ALG1L1 gene should not be transferred to ALG1L1P unless new functional data emerges.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ALG1 like 1, pseudogene (ALG1L1P).